GMP is an informal market signal, not an official price discovery mechanism or guaranteed listing return.
Quick View
Ignore GMP as a decision rule and evaluate the offer document, valuation and downside independently.
Do not treat GMP as official data.
Offer documents.
Guaranteed listing-gain messages.
Why It Matters
Grey-market activity occurs outside the recognised exchange process and lacks the transparency, surveillance and settlement protections of the formal market.
Quoted premiums can change rapidly and may reflect small, unverified or promotional transactions. Different websites can show different numbers without a common auditable source.
Even when GMP predicts listing sentiment, it says little about long-term earnings quality, capital allocation, governance or an investor’s ability to exit after the initial move.
Decision Framework
| Area | What to assess | Investor rule |
|---|---|---|
| Source | Quote provider and transaction evidence are unclear. | Treat as unverified. |
| Valuation | Premium does not calculate intrinsic value. | Use financial analysis. |
| Liquidity | Informal quotes do not guarantee executable size. | Expect change near listing. |
| Behaviour | High GMP can create fear of missing out. | Use a written subscription rule. |
Action Checklist
- Do not treat GMP as official data.
- Read the DRHP and RHP.
- Separate fresh issue from seller exit.
- Compare valuation and cash flow.
- Set a maximum portfolio allocation.
- Avoid borrowing for listing gains.
Practical Example
Evidence to Keep
- Offer documents.
- Issuer and exchange announcements.
- Valuation comparison.
- Use-of-proceeds analysis.
- Application and funding records.
- Personal investment rationale.
Warning Signs
- Guaranteed listing-gain messages.
- Daily GMP screenshots without source.
- Borrowed application money.
- Ignoring offer-for-sale.
- Applying only because subscription is high.
How to Analyse
Use a subscription checklist that would produce the same decision if GMP were unavailable. This reveals whether the investor has an investment thesis or only momentum hope.
Separate listing-day speculation from long-term ownership. They require different risk limits and evidence.
The investor should record the product, entity, amount, expected return source, maximum credible loss, liquidity, cost, holding period and exit route before transferring money. A decision that cannot be explained without a price target or influencer claim is not yet an investment thesis.
Regulations, product terms, charges, taxes and complaint procedures can change. Use the latest official document and the investor’s actual statement rather than an old screenshot or generic online table.
Investor Safety Test
First verify the legal entity and regulated role. A familiar brand, app-store listing, social-media badge or celebrity does not prove that the person receiving money is the registered intermediary.
Second verify the money and asset trail. Payment should move through the appropriate regulated account, and the investment should appear in an independent contract note, depository statement, folio record or lawful product report.
Third compare return with the risk that produces it. High yield, rapid profit, leverage, illiquidity, concentration and complex valuation are not separate from return; they are often the reason the expected return looks attractive.
Fourth preserve evidence. Statements, product documents, risk disclosures, communications, ticket numbers and complaint acknowledgements should be stored outside the app or platform being disputed.
Finally, separate a disappointing market outcome from fraud, mis-selling, unauthorised activity or service failure. The correct complaint route and available relief depend on that distinction.
Deeper Review
The review should use the same transaction or holding population across all evidence. For this topic, the main areas are source, valuation, liquidity, behaviour. If the app, contract note, depository statement, factsheet and tax record describe different positions, the investor should resolve the difference before taking another action.
Suitability has two layers: product risk and household capacity. A product can be lawful and accurately disclosed yet still be unsuitable for money needed for education, emergencies, near-term housing or debt repayment.
The investor should separate price volatility from permanent loss. Temporary market movement, issuer default, fraud, forced sale, liquidity failure and excessive cost require different controls and complaint routes.
Every review should end with a written action: hold with a stated reason, reduce concentration, seek clarification, stop further transfers, preserve evidence or escalate through the regulated entity and official platform.
Offer analysis should separate company capital from shareholder exit. Fresh proceeds may fund growth or debt reduction, while an offer-for-sale transfers money to existing holders.
Model downside without listing gain. Revenue growth, working capital, promoter record, litigation and valuation should support the decision even when subscription data and GMP are ignored.
Common Questions
Is GMP illegal?
It is an unofficial market indicator outside the formal exchange process; investors should not treat it as regulated data.
Can GMP be accurate?
It may sometimes track sentiment, but it is not verified or guaranteed.
What should replace GMP?
Offer-document analysis, valuation, business quality, governance and portfolio suitability.
Should investors borrow for an IPO?
Borrowing creates a fixed cost against uncertain allotment and listing performance.
Official Sources
Official links provide the regulatory or investor-protection framework. Product suitability and outcomes still depend on the investor’s circumstances and the current document.